Acute Coronary Syndrome
Virtual Grand Rounds

Because therapies for the acute coronary syndromes (ACS) are
continually evolving, this case-based series will keep clinicians abreast
of the key issues and important nuances that will influence the strategies they design for managing their patients with ST-elevation myocardial infarction and non–ST-elevation ACS. Through this educational initiative from the Cleveland Clinic Sydell and Arnold Miller Family Heart & Vascular Institute, experts in cardiology will offer their unique perspectives on various topics, including early invasive vs conservative management, fibrinolysis vs primary percutaneous intervention, stent thrombosis, selection and administration of antiplatelet and anticoagulant agents, and the potential role of new antithrombotic therapies. By melding cases with current data and providing participants with an opportunity to direct their questions to the faculty, this educational initiative is designed to provide a foundation for customizing therapeutic approaches to individual patients with ACS.

	ST-Elevation Myocardial Infarction: A Case Study
	Estimated Time: 1 hour Release Date: April 1, 2009 Type: Webcast	Technical Requirements: Windows Media Expiration Date: April 1, 2010 Specialties: Cardiology
	Non–ST-Elevation Myocardial Infarction: A Case Study
	Estimated Time: 1 hour Release Date: July 17, 2009 Type: Webcast	Technical Requirements: Windows Media Expiration Date: July 17, 2010 Specialties: Cardiology

Series Objectives

1. Identify which patients benefit from various types of medical and invasive therapies for unstable angina (UA)/NSTEMI.
2. Relate how specific diagnostic tools identify patients with UA/STEMI.
3. Describe the appropriate use of antiplatelet drugs during treatment for UA/STEMI.
4. Recognize which patients benefit from fibrinolytics vs PCI for the treatment of STEMI.
5. Articulate the benefits of a system of care for STEMI and identify the factors necessary for its implementation.

Target Audience 

This series is targeted to physicians who treat patients for coronary artery disease (CAD) or see patients at some point in the course of evaluation for potential UA or myocardial infarction (MI), such as primary care physicians, emergency room physicians, or cardiologists.

Ask the Expert       

Participants have the opportunity to present questions to the Activity Director, A. Michael Lincoff, MD, about the presented case through the Ask the Expert portal. To access this feature, begin the activity and enter in questions at the bottom portion of the screen.

The Cleveland Clinic Foundation Center for Continuing Education acknowledges educational grants for partial support of this activity from:
Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership
Daiichi Sankyo, Inc. and Eli Lilly and Company